Demonstrating the Utility of qEEG Methods Including MisMatch Negativity in Schizophrenia Drug Development
Time: 2:30 pm
day: EEG Focus Day
Details:
- Utilizing qEEG methods in the development of a new therapeutic mechanism for schizophrenia
- Correlating mechanism of action with positive effects on EEG spectral analysis
- Future directions for incorporating qEEG and EEG measurements of mismatch negativity as clinical endpoints
